Based on these results, there is now good evidence that increasing RNase 1 serum levels may play a role in renal dysfunction associated with COVID-19 and that increasing RNase 1 serum levels may be a potential biomarker to predict outcome in ICU patients with SARS-Cov-2 infection. This evidence concerns the gene RNASE1 and Abnormal renal physiology.